N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid is an effective mammal sialidase (neuraminidase) inhibitor[1]. N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid can also inhibite Clostridium Perfringens sialidase, which has the IC50 value of 4μM[2]. N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid is sialidase transition state analog, and has been used as an important probe for structural and mechanistic studies of sialidases[3].
N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid (50μM; 3 days) decreased the growing number of myotube induced by lactate (15mM; 3-5 days) treatment in C2C12 cells[4]. N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid (1mM; 180min) increased glutamate release from rat hippocampus neurons[5].
N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid (70-2100μmol/kg; intravenous injection; 30min) attenuated the mice blood glucose level after injection with glucose (2g/kg; i.p. ;120min) in a concentration-dependent manner[6]. N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid (10mg/kg; i.p. ; 20 days) and Tamiflu (10mg/kg; i.p. ; 20 days) treatments decreased the bleomycin (3U/kg; oropharyngeal aspiration; 1 day) induced lung fibrosis in mice[7].
References:
[1] MAGESH S, MORIYA S, SUZUKI T, et al. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1) [J]. Bioorg Med Chem Lett, 2008, 18(2): 532-7.
[2] HUNT M E, BROWN D R. Role of sialidase in Mycoplasma alligatoris-induced pulmonary fibroblast apoptosis [J]. Vet Microbiol, 2007, 121(1-2): 73-82.
[3] XIAO A, LI Y, LI X, et al. Sialidase-catalyzed one-pot multienzyme (OPME) synthesis of sialidase transition-state analogue inhibitors [J]. ACS Catal, 2018, 8(1): 43-7.
[4] DAI W, WU G, LIU K, et al. Lactate promotes myogenesis via activating H3K9 lactylation-dependent up-regulation of Neu2 expression [J]. J Cachexia Sarcopenia Muscle, 2023, 14(6): 2851-65.
[5] MINAMI A, ISHII A, SHIMBA S, et al. Down-regulation of glutamate release from hippocampal neurons by sialidase [J]. J Biochem, 2018, 163(4): 273-80.
[6] MINAMI A, FUJITA Y, SHIMBA S, et al. The sialidase inhibitor 2,3-dehydro-2-deoxy-N-acetylneuraminic acid is a glucose-dependent potentiator of insulin secretion [J]. Sci Rep, 2020, 10(1): 5198.
[7] KARHADKAR T R, PILLING D, COX N, et al. Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model [J]. Sci Rep, 2017, 7(1): 15069.
N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid是一种高效的哺乳动物唾液酸酶(神经氨酸酶)抑制剂[1]。N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid对产气荚膜梭菌唾液酸酶也有抑制作用,IC50值为4μM[2]。N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid是唾液酸酶过渡态类似物,已被用作研究唾液酸酶结构和机理的重要探针[3]。
N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid(50μM; 3 days)减少由乳酸(15mM; 3-5 days)诱导的C2C12细胞中过量的肌管的合成[4]。N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid(1mM; 180min)增加大鼠海马神经元细胞的谷氨酸释放[5]。
使用N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid(70-2100μmol/kg; intravenous injection; 30min)处理腹腔注射葡萄糖(2g/kg; i.p. ;120min)的小鼠,N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid以浓度依赖的方式降低小鼠的血葡萄糖水平[6]。N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid bleomycin减少由bleomycin(3U/kg; ; 1 day)诱导的小鼠肺纤维化。N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid(10mg/kg; i.p. ; 20 days)和Tamiflu(10mg/kg; i.p. ; 20 days)联合治疗降低了由Bleomycin(3U/kg;oropharyngeal aspiration;1day)诱导的小鼠肺纤维化程度[7]。
















